Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Analytical Method Development: Limit Test for Chloride/Sulphate Development – V 2.0

Posted on By

Analytical Method Development: Limit Test for Chloride/Sulphate Development – V 2.0

SOP for Development of Limit Test for Chloride and Sulphate in AMD Laboratory


Department Analytical Method Development
SOP No. SOP/AMD/052/2025
Supersedes SOP/AMD/052/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP defines the process for developing, standardizing, and validating limit tests for detecting chloride and sulphate impurities in APIs and excipients using visual comparison techniques with standard turbidity suspensions, in accordance with IP, USP, and Ph. Eur. guidelines.

2. Scope

This procedure applies to the Analytical Method Development (AMD) laboratory for substances where chloride and sulphate are controlled as impurity limits, typically in milligram per liter (ppm) or percentage ranges.

3. Responsibilities

  • Analytical Chemist: Develops the method, prepares standard and test solutions, and performs visual comparisons.
  • Method Reviewer: Evaluates accuracy, repeatability, and visual consistency of turbidity.
  • QA Personnel: Ensures documentation meets regulatory and GMP standards.
  • Head – AMD: Approves final method and ensures compliance with regulatory expectations.

4. Accountability

The Head of AMD is accountable for ensuring that qualitative limit tests for chloride and sulphate are developed and validated per pharmacopeial guidelines and are suitable for regulatory submissions and quality control operations.

See also  Analytical Method Development: Analytical Instrument Calibration in AMD - V 2.0

5. Procedure

5.1 Preliminary Method Review

  1. Refer to official pharmacopeial methods for limit tests:
    • IP – Appendix III A and III B
    • USP <221> – Chloride and Sulfate Tests
    • Ph. Eur. 2.4.4 (Chloride) and 2.4.5 (Sulphates)
  2. Determine the applicable impurity limit for the test substance.
  3. Record source and applicable method details in Annexure-1: Method Review Log.

5.2 Preparation of Reagents and Apparatus

  1. Prepare standard reagents as per pharmacopeia:
    • Chloride Standard Solution: 10 ppm NaCl in distilled water
    • Sulphate Standard Solution: 10 ppm K2SO4 in distilled water
    • Reagents: Nitric acid, barium chloride solution (10%), silver nitrate, etc.
  2. Use matched Nessler cylinders (50 mL capacity) for visual comparison.
  3. Ensure all glassware is chloride/sulphate-free (rinse with distilled water).

5.3 Standardization and Blank Preparation

  1. Prepare blank solution using the same volume of reagents without analyte.
  2. Prepare standard turbidity solution by adding chloride or sulphate ion solution to test volume with appropriate reagents.
  3. Incubate for 5 minutes to allow turbidity to develop fully.
  4. Observe turbidity against a black background and record visual clarity.
  5. Use this as reference standard for test comparison.

5.4 Test Sample Preparation

  1. Dissolve appropriate quantity of sample (as per monograph) in distilled water.
  2. Filter or centrifuge if sample is not clear.
  3. Transfer specified volume into Nessler cylinder.
  4. Add acidifying agent (e.g., nitric acid) followed by turbidity reagent (e.g., barium chloride for sulphate).
  5. Incubate for specified duration (usually 5 minutes).
  6. Compare turbidity visually against standard solution side-by-side under identical lighting conditions.
  7. Document comparison results in Annexure-2: Visual Comparison Record.

5.5 Visual Comparison Criteria

  1. Pass Criteria: Turbidity in test sample must not be more intense than in standard solution.
  2. If the turbidity is equal or less than the standard, record as “Complies.”
  3. If higher, repeat test with another aliquot or diluted sample.
  4. Any color interference or haziness shall be reported and investigated.

5.6 Method Optimization

  1. Perform multiple trials using known chloride/sulphate concentrations near the specification limit.
  2. Evaluate:
    • Reagent freshness and batch variability
    • Reaction time and stability of turbidity
    • Effect of light and temperature on visual comparison
  3. Record observations in Annexure-3: Optimization Log.

5.7 Method Validation (Visual Tests)

  1. As these are qualitative limit tests, full quantitative validation is not required.
  2. Perform robustness by changing reagent volumes (±10%), pH (±0.5), and incubation time (±2 mins).
  3. Perform specificity check using blank and placebo matrix.
  4. Test detection limit by preparing serial dilutions around the limit concentration.
  5. Ensure operator reproducibility with blind testing across three analysts.
  6. Summarize all validation exercises in Annexure-4: Validation Summary Report.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • IP: Indian Pharmacopoeia
  • USP: United States Pharmacopeia
  • Ph. Eur.: European Pharmacopoeia
  • QA: Quality Assurance
  • AMD: Analytical Method Development

7. Documents

  1. Method Review Log – Annexure-1
  2. Visual Comparison Record – Annexure-2
  3. Optimization Log – Annexure-3
  4. Validation Summary Report – Annexure-4

8. References

  • USP <221> – Chloride and Sulphate Limit Tests
  • IP Appendix III – Limit Tests for Inorganic Impurities
  • Ph. Eur. 2.4.4 & 2.4.5 – Limit Tests for Chloride and Sulphate
  • ICH Q2(R1) – Validation of Analytical Procedures

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Method Review Log

Analyte Pharmacopeial Reference Limit Notes Prepared By
Chloride USP <221> ≤ 0.014% Limit Test Method Sunita Reddy

Annexure-2: Visual Comparison Record

Sample ID Test Solution Clarity Standard Solution Clarity Result Analyst
API-23 Faint Turbidity Same Complies Ajay Mehra

Annexure-3: Optimization Log

Trial Parameter Changed Observation Conclusion
1 +10% Barium Chloride Increased turbidity Not acceptable

Annexure-4: Validation Summary Report

Validation Parameter Criteria Outcome Status
Specificity No interference Confirmed Pass
Reproducibility 3 analysts same result Confirmed Pass
Robustness ±10% reagent Stable turbidity Pass

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Expanded validation and added operator variability checks Audit Preparedness
See also  Analytical Method Development: Titrimetric Assay Development for Alkalinity - V 2.0
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Biosimilars: SOP for Data Integrity in CLD Operations – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version